Abstract OBJECTIVES: Total thymectomy should be performed on thymoma patients with myasthenia gravis. The aim of the present study was to investigate the risk factors of postoperative myasthenic crisis (POMC) occurrence in these patients.
INTRODUCTION
Myasthenia gravis (MG) is a neuromuscular junction (NMJ) disorder characterized by fluctuating weakness of the skeletal muscles. The mechanism underlying MG involves autoantibodies against the pre-or post-synaptic membrane of the NMJ, most commonly anti-acetylcholine receptor antibodies. In a previous study, nearly 50% of all thymoma patients developed MG [1] , and thymoma MG accounted for approximately 15% of all MG patients [2] . Total thymectomy and complete excision of the tumour and thymus tissue are recommended for medically diagnosed thymoma patients with MG. Myasthenic crisis (MC) is a lifethreatening medical emergency requiring early recognition and ventilatory support. Thymectomy is one of the numerous triggers for MC. However, few studies on the incidence rate and risk factors of postoperative myasthenic crisis (POMC) in thymoma patients with MG have been published in English. The aim of the present study was to investigate the risk factors of POMC occurrence after total thymectomy in thymoma patients with MG.
MATERIALS AND METHODS

Patient population and variables reviewed
We retrospectively reviewed the medical records of 127 thymoma patients with MG who underwent total thymectomy from 2005 to 2014 in the Department of Thoracic Surgery at Zhongshan Hospital, Fudan University. Thymoma patients with fluctuating weakness in any part of the body, e.g., ophthalmoplegia, dysphagia and dysarthria, weakness of the extremities or laboured breathing, were referred to a single †Presented at the 24th European Conference on General Thoracic Surgery, Naples, Italy, 29 May-1 June 2016.
neurologist at the hospital. The diagnosis of MG was confirmed through clinical presentations and electrodiagnostic tests, such as repeated nerve stimulations with low and high frequencies, electromyograph and simple-fibre electromyography, if necessary. Serum antibodies against the presynaptic membrane (Psm), acetylcholine receptor (AchR) and Tintin were measured using enzyme-linked immunosorbent assays, and these levels were also tested at other hospitals in Shanghai. The clinical severity of MG for all patients was graded in 5 stages according to the Osserman classification [3] . The Myasthenia Gravis Foundation of America (MGFA) classification was also used in a subset of 36 patients, mostly those evaluated more recently. Because this subset constituted only 28% of the total sample, the MGFA classification was not considered in the following statistics.
In the present study, a panel of neurologists, thoracic surgeons and anaesthesiologists determined the timing for surgery. In addition to electrodiagnostic tests of the NMJ, electrocardiography, pulmonary function and chest-computed tomography [4] with contrast were also routinely performed in the preoperative workup of the surgical candidates. Magnetic resonance imaging of the chest with contrast was performed to illustrate the relationship between the thymoma and major vasculature, such as the vena cava or innominate vein, if necessary.
The preoperative regimen of anticholinesterase and corticosteroid therapy was optimized and maintained until the time of the operation. Corticosteroids were gradually tapered to the minimal dose required to maintain remission. The intravenous infusion of immunoglobulin was only used preoperatively in a few cases of severe MG patients with contraindications to corticosteroids.
Total thymectomy was performed, including the removal of all mediastinal fatty tissue. The borders of the resection were the diaphragm caudally, the inferior horns of thyroid gland orally, and phrenic nerves bilaterally. En-block resection of the lung, pericardium, phrenic nerve and innominate vein was performed in cases of tumour involvement. The surgical approaches used in the present study included trans-sternal thymectomy in 80 patients and video-assisted thoracic surgery (VATS) in 47 patients.
We conducted multidisciplinary team meetings for thymoma patients with MG. A radiologist explained the MR or CT images of the patients, and respiratory doctors evaluated the pulmonary function of each patient. A neurologist diagnosed, staged and administered perioperative medicine therapy to the MG patients. We typically do not administer prednisone to thymoma patients with only ocular MG. We also do not prescribe perioperative prednisone for patients in stable condition without previous medical treatment. For patients with hyperthyroidism or other autoimmune diseases, we asked endocrinologists and rheumatologists to determine the treatment strategy together.
Nearly all MG patients were admitted to the intensive care unit (ICU) for postoperative care, particularly patients with moderate-to-severe MG symptoms or those who underwent trans-sternal procedures.
POMC was defined as respiratory failure resulting from NMJ disorder, which requires prompt intubation and total postoperative ventilatory support >24 h or repeated intubation and ventilatory support after extubation prior to the 30th postoperative day. Respiratory failures resulting from cardiopulmonary complications, phrenic nerve paralysis, cholinergic crisis or other reasons were excluded from POMC.
Patients with POMC were admitted to an intensive care unit for respiratory support. The general principles for the management of POMC included airway assistance and ventilation, adjusting anticholinesterases, ceasing offending drugs (e.g. b-blocker), cardiac monitoring, immunosuppressive therapy (e.g. intravenous immunoglobulins and corticosteroids), diagnosis and therapy for infection, prophylaxis for deep vein thrombosis and others. We used non-invasive mechanical ventilation in patients with mild-to-moderate symptoms. If the respiratory failure was relieved after the original therapy, non-invasive ventilation support was continued; otherwise, the patients were intubated.
The following clinical variables were reviewed: age, gender, period of symptoms, smoking history, preoperative therapy, the forced expiratory volume in one second/predicted value ratio, bulbar syndrome, major comorbidities, surgical approach, World Health Organization (WHO) histologic classification, Masaoka staging, tumour size, complete resection (R0) or not, postoperative complications and POMC incidence, duration of mechanical ventilation, the need for reintubation, hospital stay and ICU stay.
The research protocol was examined and approved by the ethics board at our institution prior to the study.
Statistical analysis
Statistical analyses were performed using SPSS 19.0 software (SPSS, Inc., Chicago, IL, USA). The variables were analysed as proportions, means or medians according to their nature. The risk of POMC associated with selected factors was initially evaluated using a simple logistic regression analysis to determinate the odds ratios (ORs) and 95% confidence intervals (CIs). Factors with a P-value of <0.05 were subsequently used in stepwise multiple logistic regression analyses to estimate ORs and CIs. A P-value of <0.05 was regarded as significant.
We calibrated the model by comparing the predicted and observed risk and calculating the Hosmer-Lemeshow [5] and C statistic.
RESULTS
Clinicopathological factors of the total patient population
The clinicopathological factors of all patients (n = 127) are listed in Table 1 . The study population included 68 men and 59 women. The median age at surgery was 52 years (range, 17-74 years). Forty-five patients (35%) had not been administered any anti-MG treatment because their MG symptoms were not severe enough to begin the related treatment prior to surgery, and after consultation with the neurologists, these patients were administered anti-MG drugs postoperatively and subsequently followed up by the neurologists. The remaining 82 patients (65%) were treated preoperatively with prednisolone, pyridostigmine or a combination of both drugs. Two patients (2%) received preoperative intravenous immunoglobulin (IVIG) and pyridostigmine.
We performed trans-sternal thymectomy in 80 (63%) patients. VATS thymectomy was performed in 47 (37%) cases, including 5 cases with a bilateral VATS approach, 6 cases with a left-side approach and 36 cases with a right-side approach. The average length of the surgical procedure was 109.5 ± 32.3 min (range 49-212). No patient died in the 30 days after the procedure.
Postoperative myasthenic crisis cases and intensive care unit stay
Postoperative complications occurred in 18 (14%) patients: specifically, POMC was diagnosed in 13 (10%) cases (Table 2) . Among these patients, 2 patients required prolonged mechanical ventilation and 11 patients were reintubated for respiratory failure. Other major complications included phrenic nerve injury in 5 cases, recurrent nerve injury in 1 case, atrial fibrillation in 1 case and pneumonia in 1 case. The median length of mechanical ventilation in POMC cases was 9 days (range, 2-28 days). The median ICU length of stay was 10 days (range, 3-31 days), and the median ICU stay in non-POMC cases was 2 days (range, 0-3 days).
Predictors of postoperative myasthenic crisis according to the univariate analysis
The results of the univariate analysis of potential risk factors for POMC are summarized in Table 3 . Based on the analysis, Osserman stage IIA-IV (OR = 4.928, 95% CI = 1.286-18.882, P = 0.01), bulbar symptoms (OR = 3.828, 95% CI = 1.112-13.176, P = 0.04), forced expiratory volume in one second/predicted value ratio <70% (OR = 4.856, 95% CI = 1.380-17.081, P = 0.02) and WHO type B2/B3 thymomas (OR = 8.118, 95% CI = 1.020-64.590, P = 0.03) were associated with the occurrence of POMC.
Predictors of postoperative myasthenic crisis according to the multiple analyses
We also conducted a multivariate logistic regression analysis, including the 4 factors with a P-value <0.05 identified by univariate analysis. Of these, WHO histologic-type B2/B3 (OR = 10.041, 95% CI = 1.228-82.090, P = 0.03) and Osserman stage IIA-IV (OR = 5.953, 95% CI = 1.506-23.538, P = 0.01) were identified as independent predictors of POMC (Table 4) .
DISCUSSION
Thymoma is typically comorbid with MG. Previous studies have shown that 24.5-40% of thymoma patients develop MG, and 15-20% of MG patients are diagnosed with thymoma [6] . Thymomas frequently occur among male patients older than 40 years at the onset of MG [7] . A recent randomized trial showed that extended trans-sternal thymectomy could improve clinical outcomes over a 3-year period in patients with nonthymomatous MG [8] .
Radical excision of the neoplasm with all thymus tissue is also indicated in thymoma patients with MG. The long-term neurologic prognosis of extended thymectomy in thymoma patients with MG and age-matched nonthymomatous MG patients can be similar [9] .
MC is a life-threatening form of respiratory weakness in MG patients. Numerous factors, including surgery, drugs, thymoma, pneumonia and pregnancy, have been reported as the cause of MC [10] . POMC is the most important complication and can be a major cause of death in MG patients Thus, predicting the risk factors of POMC is vital to provide better treatment for high-risk patients and decrease the mortality of thymectomy in thymoma patients with MG. Several studies have investigated the risk factors for POMC in MG patients, and MG severity, preoperative MC history, a long MG duration, and poor pulmonary function have been reported as risk factors [11, 12] . However, the risk factors for POMC in thymoma patients with MG have not been evaluated. The incidence rate of POMC was 11% and no patient died in the 30-day postoperative period in the present study. Romi et al. [9] reported a 35.2% incidence rate of POMC in thymoma patients with MG, which was much higher than the results obtained in the present study. This difference might reflect the inclusion of more severe MG cases in the previous study than in the present study. For instance, a total of 19.7% of the patients in the previous study had a history of preoperative MC, while there was no preoperative MC in the present study.
The surgical procedure is known to significantly impact the development of POMC. For instance, median sternotomy extended thymectomy has been associated with the resection of thymic tissue in 85-95% of cases [13] . Ectopic thymic tissue in perithymic and pericardial fields may be left in minimally invasive thymectomy, suggesting a negative neurologic effect at long-term follow-up [14] . However, some authors have shown that VATS thymectomy can remove the intact thymus and all of the mediastinal fat tissue, including ectopic thymic tissue, with lower complication rates and a better aesthetic appearance [15, 16] . In these studies, VATS thymectomy produced a long-term clinical outcome comparable to that of the extended trans-sternal approach, and the complete remission rates ranged from 30% to 60% [15, 16] . The VATS approach is less invasive than the trans-sternal approach and may decrease the occurrence of POMC. In the present study, we did not identify surgical procedure as an independent risk factor for POMC. However, the present study was retrospectively designed, and a selection bias existed between the trans-sternal group and VATS thymectomy group. In particular, most of the VATS thymectomy procedures were performed in recent years. We also prefer to perform VATS procedures for small thymomas (typically not more than 4 cm in diameter). Because the VATS thymectomy procedure has drawn increasing attention, additional studies are warranted to clarify whether this procedure is beneficial to decrease the risk of POMC.
Ando et al. [17] reported that a preoperative history of MC and unstable MG were predictive factors for POMC. Medical therapies, including preoperative steroid therapy [18] , perioperative high-dose steroid therapy [19] and preoperative administration of plasma exchange [20] , have been reported as safe and promising for managing MG patients and may reduce the incidence of POMC by improving disease status. Indeed, preoperative plasmapheresis or the intravenous infusion of immunoglobulin can remove a significant amount of circulating pathogenic antibodies [21] . Some clinical centres preoperatively perform plasmapheresis or IVIG treatment on all thymoma patients with MG [22] . However, there is still no consensus on this issue. Thymomatous MG has a relatively short disease duration prior to surgery [23] , and the MG status in these cases may not be as severe as nonthymomatous MG. In the present study, only 2 patients (2%) received preoperative IVIG for economic reasons in China. IVIG and plasmapheresis remain expensive and are reimbursed through insurance. We acknowledge that this issue is an important variable, although the number of individuals in this subgroup was too small to be precisely evaluated in the present study.
The results of the multivariate analysis revealed type B2/3 thymoma as an independent risk factor for POMC. Okumura et al. [24] reported an increased proportion of tumour-associated lymphocytes in AB, B1 and B2 thymomas and an increased MG occurrence in type B1 and B2 thymomas. MG was also more frequently reported in type B1-3 thymomas (35-49%) than in type A and AB (25-26%) thymomas [4] . Type B1/B2/B3 thymoma histology was also recently identified as a risk factor for the development of postthymectomy MG [25] . The results of the present study are consistent with the results of the abovementioned studies, suggesting a strong correlation between B2/3 thymomas and POMC in thymoma MG.
We identified Osserman stage IIA-IV as an independent risk factor for POMC in thymoma MG. Several other studies have reported similar results in MG patients. Gracey et al. [26] reported that MG patients at Osserman stage III-IV had an extremely high incidence of postoperative respiratory failure. Chu et al. [27] identified Osserman stage (IIB-IV), thymoma and major postoperative complications as independent predictors of POMC in MG patients. Leuzzi et al. [12] also reported Osserman-stage IIB-IV, body mass index > _28, previous history of myasthenic crises, longer duration of MG and lung resection as independent predictors of POMC. We speculate that bulbar symptoms and poor preoperative lung function might also serve as risk factors for POMC in thymoma MG patients. Loach et al. [28] reported that a vital capacity of <2.0 l and preoperative bulbar symptoms were associated with postoperative artificial ventilation. Watanabe et al. [11] identified the existence of preoperative bulbar symptoms as a risk factor for POMC in MG patients. Leventhal's scoring system, which predicts the need for postoperative mechanical ventilation in MG [29] , also considers lung functional volumes and the presence of concomitant respiratory diseases. Naguib et al. [30] identified 7 risk factors correlated with the need for postoperative ventilation in MG patients, including forced vital capacity (FVC), forced midexpiratory flow between 25 and 75% of the forced vital capacity (FEF 25-75%), maximum expiratory flow at 50% of the forced vital capacity (MEF), their percentages of the predicted values, and sex. In the present study, bulbar symptoms and forced expiratory volume in one second/predicted value ratio showed a significant relationship with POMC in the univariate analysis but not in the multivariate analysis, likely reflecting the insufficient number of the cases included in the present study.
Limitations
The present study had several limitations. First, this study was retrospectively designed, and all patients were from 1 clinical centre, indicating the potential for selection bias. Second, the number of thymoma MG patients may not have been sufficiently large for a thorough multivariate analysis. Third, the MG status of the patients was not graded according to the MGFA classification. Thus, largescale analyses, including prospective clinical trials in multiple centres, should be performed to further address this subject.
CONCLUSION
In conclusion, the results of the present study show that Osserman stage (IIA-IV) and WHO type B2/B3 thymoma are independent risk factors for POMC in thymoma patients with MG who have undergone total thymectomy. Therefore, adequate perioperative care should be provided to these patients. Additional studies are needed to establish the sufficient perioperative management of these patients.
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